Leukemia Diagnosis 2.0: Revolutionizing advanced and Futuristic Point-of-Care Detection and Monitoring.
Emerging portable diagnostic devices powered by AI could make leukemia testing faster and more accessible, especially in under-resourced healthcare settings.
This review surveys the landscape of advanced point-of-care diagnostic platforms for leukemia detection and monitoring, integrating biosensor technology, microfluidics, AI, and portable devices that could transform decentralized hematologic cancer diagnostics. The review identifies technologies closest to clinical translation and the barriers remaining.
What the study was
- Study design
- Narrative/state-of-the-art review
- Population
- Patients with leukemia; point-of-care diagnostic context
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Critical Reviews in Oncology/Hematology
Why it surfaced
Directly addresses hematologic malignancy diagnostics + AI/ML/point-of-care; strong watchlist match across 3 topics; Crit Rev Oncol Hematol is the field's primary review journal.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.